During the past decade, University of North Carolina Lilongwe (12001) conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of North Carolina Lilongwe (12001)" #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 3 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 3 trials as a collaborator and "National Institute of Mental Health (NIMH)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "University of North Carolina Lilongwe (12001)" are "HIV Infection" (2 trials), "Malaria" (2 trials) and "HIV Infections" (1 trials). Many other conditions were trialed in "University of North Carolina Lilongwe (12001)" in a lesser frequency.

Most popular intervention types in "University of North Carolina Lilongwe (12001)" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Artemether/Lumefantrine (AL)" (1 trials), "Cohort 1" (1 trials), "Lamivudine" (1 trials), "Lopinavir/Ritonavir" (1 trials) and "Nevirapine" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of North Carolina Lilongwe (12001)" are 3 trials for "All" genders.

Currently, there are NaN active trials in "University of North Carolina Lilongwe (12001)". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in University of North Carolina Lilongwe (12001), undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of North Carolina Lilongwe (12001), 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".